Clinical Features and Key Prognostic Indicators of Growth Hormone-Secreting Pituitary Adenomas: A Retrospective Study of 344 Cases
Yu Zhang, Zenghua Mi, Hongyu Wu, Xin Ma, Long Xi, Zhijun Yang, Pinan Liu · 2026
Read Clinical Features and Key Prognostic Indicators of Growth Hormone-Secreting Pituitary Adenomas: A Retrospective Study of 344 Cases by Yu Zhang, Zenghua Mi, Hongyu Wu, Xin Ma, Long Xi, Zhijun Yang, Pinan Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13298231.txt.
Description
Yu Zhang and a team report clinical features and prognosis for growth hormone-secreting pituitary tumours, in a 2026 retrospective study. These tumours cause acromegaly and serious complications, and surgery is the main treatment. Their analysis covered 344 patients, searching for factors tied to hormone non-remission or recurrence after removal.
Recurrence itself, high hormone levels before surgery, and higher Knosp grades, which grade tumour invasion toward nearby vessels, emerged as key risk factors. The team also built prediction models for non-remission and recurrence risk. They propose the results can sharpen patient stratification and follow-up planning, though the study rests on past records from clinical care.
Catalog record
| CREATOR | Yu Zhang, Zenghua Mi, Hongyu Wu, Xin Ma, Long Xi, Zhijun Yang, Pinan Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |